Crosstalk between peroxisome proliferator-activated receptor-gamma and angiotensin II in renal tubular epithelial cells in IgA nephropathy
Our recent study suggested that peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist attenuates inflammatory response in activated tubular epithelial cells in IgA nephropathy (IgAN). Here, we explore thiazolidinediones as new therapeutic additives to established treatment regime of...
Ausführliche Beschreibung
Bibliographische Detailangaben
Veröffentlicht in: | Clinical immunology (Orlando, Fla.). - 1999. - 132(2009), 2 vom: 17. Aug., Seite 266-76
|
1. Verfasser: |
Xiao, Jing
(VerfasserIn) |
Weitere Verfasser: |
Leung, Joseph C K,
Chan, Loretta Y Y,
Tang, Sydney C W,
Lai, Kar Neng |
Format: | Online-Aufsatz
|
Sprache: | English |
Veröffentlicht: |
2009
|
Zugriff auf das übergeordnete Werk: | Clinical immunology (Orlando, Fla.)
|
Schlagworte: | Journal Article
Research Support, Non-U.S. Gov't
2-chloro-5-nitrobenzanilide
Angiotensin II Type 1 Receptor Blockers
Anilides
Culture Media, Conditioned
Immunoglobulin A
Interleukin-6
NF-kappa B
PPAR gamma
mehr...
Receptor, Angiotensin, Type 1
Thiazolidinediones
Rosiglitazone
05V02F2KDG
Intercellular Adhesion Molecule-1
126547-89-5
Extracellular Signal-Regulated MAP Kinases
EC 2.7.11.24
Losartan
JMS50MPO89 |